-
-
-
-
-
-
-
NextPlat expects sequential growth in 340B revenue for Q4 2025
-
-
-
-
-
-
-
NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results
-
-
-
-
-
-
-
NextPlat Reports Record Consolidated Q1 2024 Revenues of $17.5 Million Compared to $2.9 Million in Q1 2023 (508% Increase) as Quarterly Margins Improve to 27.5%
-
-
-
-
-
-
-
PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings
-
-
1,185,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

